Rule is a software professional who founded Translational Software to accelerate the process of bringing molecular diagnostics from the bench to the bedside. Prior to this, he had a 14-year career at Microsoft, holding a variety of program management positions, including roles in providing Internet access to MSN, pioneering virtual private networking products, and integrating instant messaging with voice over IP networks. Rule became fascinated with bioinformatics in 2004 and founded the BioIT Alliance from within Microsoft.
Fetter has implemented and overseen the commercialization and reimbursement processes for over 60 unique complex diagnostic companies releasing new, high-complexity laboratory testing services to the healthcare market. He currently oversees the diagnostic services division of XIFIN, which delivers SaaS-based RPM, LIS, and physician diagnostic applications, in addition to providing consultative and reimbursement services to over 40 complex diagnostic companies at various stages of commercialization and third-party payer contracting. Fetter also oversees the development and commercialization of new, web-based software products at XIFIN, catered to high-complexity testing laboratories. In addition to actively overseeing XIFIN’s large diagnostic services division, Fetter consults with laboratories and biotech companies on developing physician adoption for novel diagnostic products. As such, he projects cash flow for covered and non-covered services, implements successful reimbursement and appeals strategies, and effectively manages the relationship between sales and reimbursement for new medical technology.
Prior to joining TSI, Sibony served as Vice President of Global Sales for Harvard Bioscience, a global developer of a broad range of tools to advance life science research and regenerative medicine including the Biochrom range of Amino Acid Analyzers screening and monitoring for Inborn Errors of Metabolism. Previous to Harvard Bioscience, Mr. Sibony served as Global Sales Effectiveness Manager at Corning Life Sciences, a division of Corning Inc. In this role, he oversaw global sales operations and strategy development for this approximately $800 million division. Prior to this, he served in progressive positions at the medical technology company Becton, Dickinson & Company; as Regional Business Manager at BD Biosciences Discovery Labware, he oversaw 12 sales territories with combined value of $45 million.